Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Ark Therapeutics Group plc       GB0034251727

 SummaryChartsNewsCalendarCompanyFinancialsRevisions 
Financials ( GBP)
Sales 2013 -
EBIT 2013 -
Net income 2013 -
Debt 2013 -
Yield 2013 -
Sales 2014 -
EBIT 2014 -
Net income 2014 -
Debt 2014 -
Yield 2014 -
PER 2013 0,08
PER 2014 -
Capi. / Sales 2013 0
Capi. / Sales 2014 -
Capitalization 9,70 M
More Financials
Company
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on ARK THERAPEUTICS GROUP PLC
04/02 PREMIER VETERINARY : MOON Announces Merger of Four Members: IVG Hospitals, Premi..
03/02 ALLERGY THERAPEUTICS : Ups Profit, Revenue, Market Share In First Half
02/03 ARK THERAPEUTICS : Seals Deal To Buy Majority Stake In Premier Veterinary (CORRE..
01/28 ARK THERAPEUTICS : Seals Deal To Buy Majority Stake In Premier Veterinary
01/12 ALLERGY THERAPEUTICS : To Post 4% Rise In First-Half Revenue
2014 ARK THERAPEUTICS GROUP PLC : Reverse Split: 1 for 100
2014 ARK THERAPEUTICS : Posting of Circular
2014 ARK THERAPEUTICS : Says Proposed Reverse Takeover Plan Progressing Well
More news
Sector news : Generic Pharmaceuticals
07:20p AKORN : EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities C..
06:13p AKORN : SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses o..
04:48p ELI LILLY : Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval
More sector news : Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF